InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-11.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Mathers Edward T, Director. Director active across 9 companies, notably Monte Rosa Therapeutics, Inc.. Cumulatively, 17 reports have been logged. Split: 3 buys · 0 sell. Total volume traded: €3.8m. History available since 11 April 2022. The latest transaction was disclosed on 12 March 2026 (J). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Mathers Edward T
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
4,199 shares0Common StockSEC:0001193125-26-108351:0
207,100 shares@ US$11.1167.8% of flowCommon StockSEC:0001193125-26-104715:0
Canonical exit: 8 Jun 2026 (T+90)
4,198 shares0Common StockSEC:0001193125-26-091684:0
1,619,240 sharesCommon StockSEC:0001193125-26-046664:0
3,911 shares0Class A Common StockSEC:0001193125-26-000942:0
189,195 shares@ US$0.01100.0% of flowCommon StockSEC:0001193125-25-232136:0
4,125 shares0Class A Common StockSEC:0001193125-25-228402:0
4,694 shares0Class A Common StockSEC:0000950170-25-093063:0
4,000 sharesCommon StockSEC:0000950170-25-089052:0
2,580 shares0Class A Common StockSEC:0000950170-25-049473:0
1,023,103 sharesCommon StockSEC:0000950170-24-107558:0
3,000 sharesCommon StockSEC:0000950170-24-077346:0
17,857 shares@ US$56.00100.0% of flowCommon StockSEC:0000950170-24-047681:0
Canonical exit: 21 Jul 2024 (T+90)
333,333 shares@ US$3.00100.0% of flowCommon StockSEC:0001209191-23-042802:0
Canonical exit: 15 Oct 2023 (T+90)
5,771 shares0Common StockSEC:0001209191-23-016175:0
948,948 shares@ US$1.90100.0% of flowCommon StockSEC:0001209191-22-024323:0
2,715,968 sharesCommon StockSEC:0001209191-21-044044:0
17 of 17 declarations
About Mathers Edward T
Mathers Edward T is Administrateur and has filed 17 filings in total. In the 17 most recent filings held, cumulative purchases amount to EUR 3809047, sales to EUR 0, and the period runs from 2021-06-30 to 2026-03-16. Among the main filings are transactions involving Korro Bio, Inc., NeueHealth, Inc., Rhythm Pharmaceuticals, INC., Trevi Therapeutics, Inc. and Savara Inc.
